carbamates has been researched along with Day Blindness in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Repaglinide is a prandial glucose regulator indicated for management of type 2 diabetes." | 1.33 | Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study. ( Marshall, V; Shakir, S; Wilton, L, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Upshaw, J | 1 |
| MacLean, B | 1 |
| Losek, JD | 1 |
| Marshall, V | 1 |
| Wilton, L | 1 |
| Shakir, S | 1 |
2 other studies available for carbamates and Day Blindness
| Article | Year |
|---|---|
Anisocoria and topical carbamate exposure: illustrative case report.
Topics: Administration, Topical; Adolescent; Anisocoria; Carbamates; Emergency Service, Hospital; Female; Fo | 2010 |
Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study.
Topics: Aged; Carbamates; Cause of Death; Cohort Studies; Diabetes Mellitus, Type 2; Drug Prescriptions; Eng | 2006 |